AAAAAA
Results:
1-12
|
Results: 12
Authors:
Laan, RFJM
van Riel, PLCM
van de Putte, LBA
Citation: Rfjm. Laan et al., Leflunomide and methotrexate, CURR OP RH, 13(3), 2001, pp. 159-163
Authors:
Bullens, PHJ
van Loon, CJM
Malefijt, MCD
Laan, RFJM
Veth, RPH
Citation: Phj. Bullens et al., Patient satisfaction after total knee arthroplasty - A comparison between subjective and objective outcome assessments, J ARTHROPLA, 16(6), 2001, pp. 740-747
Authors:
van Ede, AE
Laan, RFJM
Rood, MJ
Huizinga, TWJ
van de Laar, MAFJ
van Denderen, CJ
Westgeest, TAA
Romme, TC
de Rooij, DJRAM
Jacobs, MJM
de Boo, TM
van der Wilt, GJ
Severens, JL
Hartman, M
Krabbe, PFM
Dijkmans, BAC
Breedveld, FC
van de Putte, LBA
Citation: Ae. Van Ede et al., Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis - A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study, ARTH RHEUM, 44(7), 2001, pp. 1515-1524
Authors:
Kroot, EJJA
Nieuwenhuizen, MG
Malefijt, MCD
van Riel, PLCM
Pasker-de Jong, PCM
Laan, RFJM
Citation: Ejja. Kroot et al., Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease, ARTH RHEUM, 44(6), 2001, pp. 1254-1260
Authors:
van Ede, AE
Laan, RFJM
Blom, HJ
Huizinga, TWJ
Haagsma, CJ
Giesendorf, BAJ
de Boo, TM
van de Putte, LBA
Citation: Ae. Van Ede et al., The C677T mutation in the methylenetetrahydrofolate reductase gene - A genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients, ARTH RHEUM, 44(11), 2001, pp. 2525-2530
Authors:
van Heereveld, HAEM
Laan, RFJM
van den Hoogen, FHJ
Malefijt, MCD
Novakova, IRO
van de Putte, LBA
Citation: Haem. Van Heereveld et al., Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement, ANN RHEUM D, 60(10), 2001, pp. 974-976
Authors:
Reid, DM
Hughes, RA
Laan, RFJM
Sacco-Gibson, NA
Wenderoth, DH
Adami, S
Eusebio, RA
Devogelaer, JP
Citation: Dm. Reid et al., Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial, J BONE MIN, 15(6), 2000, pp. 1006-1013
Authors:
Kroot, EJJA
Laan, RFJM
Citation: Ejja. Kroot et Rfjm. Laan, Bone mass in rheumatoid arthritis, CLIN EXP RH, 18(5), 2000, pp. S12-S15
Authors:
Hen, SSKTA
Geurts, ACH
Bosch, PV
Laan, RFJM
Mulder, T
Citation: Sskta. Hen et al., Postural control in rheumatoid arthritis patients scheduled for total kneearthroplasty, ARCH PHYS M, 81(11), 2000, pp. 1489-1493
Authors:
Laan, RFJM
Jansen, TLTA
van Riel, PLCM
Citation: Rfjm. Laan et al., Glucocorticosteroids in the management of rheumatoid arthritis, RHEUMATOLOG, 38(1), 1999, pp. 6-12
Authors:
te Boekhorst, PAW
Barrera, P
Laan, RFJM
van de Putte, LBA
Citation: Paw. Te Boekhorst et al., Hepatotoxicity of parenteral gold therapy in rheumatoid arthritis: A case report and review of the literature, CLIN EXP RH, 17(3), 1999, pp. 359-362
Authors:
Eijsbouts, A
van den Hoogen, F
Laan, RFJM
Hermus, ARMM
Sweep, FCGJ
van de Putte, L
Citation: A. Eijsbouts et al., Treatment of rheumatoid arthritis with the dopamine agonist quinagolide, J RHEUMATOL, 26(10), 1999, pp. 2284-2285
Risultati:
1-12
|